| Feature Story: |
Stryker Gaining Leverage in Spine Market with $1.4 Billion K2M Acquisition |
According to a recent news release by the Wall Street Journal, Stryker will acquire rival spine company K2M Group Holdings in a deal valued at approximately $1.4 billion. K2M will become a wholly-owned subsidiary of Stryker, joining their spine division to broaden its current traditional and minimally invasive product offerings.
“Joining Stryker will be a very exciting next chapter for our global team and surgeon customers around the world,” said Chairman, Chief Executive Officer, and President of K2M, Eric D. Major in a press release. “Stryker’s established leadership in the orthopedic and neurosurgical market, combined with...
Click here to read more |
|
|
 Will you or your team be at NASS 2018 in Los Angeles on September 26-29? Visit us at booth #1963 for exclusive conference discounts.
iData’s Spine Team will be attending the 33rd North American Spine Society (NASS) Annual Meeting at the Los Angeles Convention Centre in Los Angeles, California on September 26-29. Please visit us on the show floor at booth #1963 and learn about our latest market research on the spine industry.
At the show, we will be conducting a new Minimally Invasive Spinal Implant and VCF Physician Product Preference Survey with responses from those in attendance. This will be a great opportunity to...
read more}
|
|
 Solvay, a leading global supplier of specialty polymers, announced that its Ixef® polyarylamide (PARA) resin delivered the high stiffness and biocompatibility that Reign Medical needed to develop its revolutionary new Clench® compression staple system, a single-use bone staple kit for orthopedic procedures targeting the hand and foot.
Reign Medical’s innovative Clench® Staple System kit comprises a fully disposable sterile surgical tool set for fixating hand and foot bone fragments, osteotomy fixation and joint arthrodesis. Its design utilizes a patented...
read more}
|
|
 DePuy Synthes has recently announced the launch of their new implantable device designed to treat patients suffering from degenerative disc disease, the CONCORDE LIFT Interbody Implant.
According to MDDI Online, “the implantable device was designed as part of a new procedural solution that can simplify minimally invasive spine surgery procedures used to help restore disc height in the spinal column. This is typically done through the process of spinal fusion, a surgical procedure that places bone or bone-like material within the space between...
read more}
|
|
 San Diego, California-based NuVasive, Inc. has announced the U.S. launch of AttraX Scaffold, the company’s absorbent ceramic-collagen bone graft with an optimized surface.
According to the company, “Unlike traditional ceramic materials that do not by themselves generate bone formation when implanted in an intramuscular site, AttraX Scaffold has unique microstructure and microporosity that are optimized for bone formation in this environment. The AttraX surface technology, through its carefully defined and tightly controlled features at the submicron scale, drives the differentiation of mesenchymal stem cells into bone-forming osteoblasts without added growth factors.”
“Available in strips, blocks and...
read more}
|
|
 Arcuro Medical Ltd. (“Arcuro”), a portfolio company of The Trendlines Group Ltd. (“Trendlines”), announced that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its SuperBall™ meniscus repair system.
Meniscus tears are a common occurrence in many population groups: professional athletes, people who engage in daily sport activities, the ageing population, and people predisposed to cartilage problems.
To maintain knee functionality, current practice seeks to avoid...
read more}
|
|
|
|
|
|
|
|
